Therapeutic methods using electromagnetic radiation

• US 7,918,779 B2
• Filed: 10/19/2007
• Issued: 04/05/2011
• Est. Priority Date: 06/26/2001
• Status: Active Grant

• Current Assignee: Photomed Technologies, Inc.
• Original Assignee: Photomed Technologies, Inc.
• Inventors: Gardiner, Allan, Haber, Constance
• Primary Examiner(s): Lacyk; John P
• Application Number:
  US11/975,665
• Publication Number:
  US 20080051858A1
• Time in Patent Office: 1,264 Days
• Field of Search: 600 9- 15, 600/427, 600/474, 600/549, 600/557, 607 88- 90, 607/100, 607/102, 607108-111
• US Class Current: 600/9
• CPC Class Codes: A61B 5/0531 Measuring skin impedance
• CPC Class Codes: A61B 5/389 Electromyography [EMG]
• CPC Class Codes: A61B 5/395 Details of stimulation, e.g. nerve stimulation to elicit EMG response
• CPC Class Codes: A61B 5/4519 Muscles A61B5/389, A61B5/224 take precedence
• CPC Class Codes: A61B 5/4528 Joints A61B5/4533, A61B5/4538 take precedence
• CPC Class Codes: A61N 2005/0663 Coloured light
• CPC Class Codes: A61N 5/0619 Acupuncture
• CPC Class Codes: G01J 2003/1213 Filters in general, e.g. dichroic, band
• CPC Class Codes: G01J 3/02 Details
• CPC Class Codes: G01J 3/0229 using masks, aperture plates, spatial light modulators or spatial filters, e.g. reflective filters
• CPC Class Codes: G01J 3/0232 using shutters
• CPC Class Codes: G01J 3/10 Arrangements of light sources specially adapted for spectrometry or colorimetry

Abstract

This invention provides methods for treating a variety of disorders using localized electromagnetic radiation directed at excitable tissues, including nerves, muscles and blood vessels. By controlling the wavelength, the wavelength bandpass, pulse duration, intensity, pulse frequency, and/or variations of those characteristics over time, and by selecting sites of exposure to electromagnetic radiation, improvements in the function of different tissues and organs can be provided. By monitoring physiological variables such as muscle tone and activity, temperature gradients, surface electromyography, blood flow and others, the practitioner can optimize a therapeutic regimen suited for the individual patient.

Claims

1. A method for treating neuronal pain in a subject comprising the step of:

exposing a first site of an affected tissue associated with said pain to localized electromagnetic radiation only within a wavelength range of about 400 to about 700 nm, a bandwidth only within the wavelength range, and a controlled variable selected from the group consisting of;

(i) the bandwidth; and

(ii) a wavelength variation over time (“

VOT”

);

said treating resulting in a decrease in said neuronal pain.

2. The method of claim 1, said neuronal pain is associated with a disorder selected from the group consisting of carpal tunnel syndrome, peripheral neuropathy, tarsal tunnel syndrome, dental pain, gingivitis, and traumatic injury.

3. The method of claim 1, further comprising exposing a contralateral site associated with said pain to localized electromagnetic radiation.

4. The method of claim 1, further comprising exposing said subject to electromagnetic radiation at a site proximal to said first site.

5. The method of claim 1, further comprising exposing a site near C1 to localized electromagnetic radiation.

21. The method of claim 1, said first site is one of an electrodiagnostic point, an acupuncture point, a trigger point, a meridian, and an area along a nerve distribution to said tissue.

22. The method of claim 1, said wavelength range of the electromagnetic radiation including a central wavelength and said VOT changes by a predetermined wavelength variation around said central wavelength.

23. The method of claim 1, said wavelength VOT being in the range of about 1 nm to about 100 nm.

24. The method of claim 1, said wavelength VOT occurring with a cycle time in the range of about 1 sec to about 100 sec.

6. A method for reducing pain due to a neuronomuscular abnormality in a subject, comprising the step of:

exposing a portion of a nerve or muscle associated with said pain to a beam of localized electromagnetic radiation only within a wavelength range of about 400 nm to about 700 nm, a bandwidth only within the wavelength range, and a controlled variable selected from the group consisting of;

(i) the bandwidth; and

(ii) a wavelength variation over time;

said treating resulting in a decrease in said pain.

7. The method of claim 6, said neuromuscular abnormality is a headache and the exposing step includes exposing a portion of the occipital nerve to a beam of electromagnetic radiation.

8. The method of claim 7, said portion of the occipital nerve being exposed to the beam of electromagnetic radiation at an angle of about 45°

to the cephalad.

9. The method of claim 7, further comprising exposing said subject to a beam of electromagnetic radiation at a site near the inner canthus of the eye.

10. The method of claim 7, the wavelength range of the electromagnetic radiation being about 577 nm to about 597 nm.

11. The method of claim 7, the wavelength range of the electromagnetic radiation being about 577 nm to about 622 nm.

12. The method of claim 6, said neuromuscular abnormality being temporomandibular joint syndrome.

13. The method of claim 12, said wavelength range of the electromagnetic radiation being about 577 nm to about 622 nm.

14. The method of claim 12, said wavelength range being about 455 nm to about 492 nm.

15. The method of claim 6, said neuromuscular abnormality being trigeminal neuralgia.

16. The method of claim 15, said nerve being the trigeminal nerve.

25. The method of claim 6, said exposing step including moving said beam of electromagnetic radiation between two locations of said nerve or muscle.

17. A method for treating a symptom associated with an abnormality of vascular perfusion, comprising the step of:

exposing a portion of a tissue associated with said abnormality of vascular perfusion to an effective amount of a localized electromagnetic radiation only within the visible wavelength range with a bandwidth only within the visible wavelength range and a controlled variable selected from the group consisting of;

(i) the bandwidth; and

(ii) a wavelength variation over time;

said treating resulting in a decrease in said symptom.

18. The method of claim 17, said abnormality of vascular perfusion being associated with a disorder selected from the group consisting of complex regional pain syndrome, sympathetic dystonia, reflex sympathetic dystrophy, sympathetic hyperactivity, Reynaud'"'"'s syndrome, muscle spasm, and peripheral neuropathy.

19. The method of claim 17, said tissue being a blood vessel selected from the group consisting of the abdominal aorta, a femoral artery, a brachial artery, and the popliteal artery.

20. The method of claim 17, said tissue being a nerve associated with said abnormality of vascular permeability.